LIVE on April 23rd: Has Covid impacted India's long-term growth potential?
Here is the latest financial fact sheet of Elder Pharma. For more details, see the Elder Pharma quarterly results and Elder Pharma share price and chart. For a sector overview, read our pharmaceuticals sector report.
% ch | % | 5.0 |
No. of shares | m | 20.54 |
% ch week | % | 5.0 |
% ch 1-mth | % | 27.1 |
% ch 12-mth | % | -64.5 |
52 week H/L | Rs | 118.8/20.4 |
No. of Mths Year Ending |
12 Mar-11* |
12 Mar-12* |
12 Mar-13* |
15 Jun-13* |
12 Jun-14* |
5-Yr Chart Click to enlarge
|
---|
ELDER PHARMA EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 440 | 435 | 416 | 416 | 380 | |
Low | Rs | 321 | 298 | 202 | 202 | 188 | |
Sales per share (Unadj.) | Rs | 470.0 | 649.8 | 799.3 | 799.3 | 491.2 | |
Earnings per share (Unadj.) | Rs | 31.3 | 35.2 | 40.1 | 40.1 | -3.2 | |
Diluted earnings per share | Rs | 31.3 | 35.2 | 40.1 | 40.1 | -3.2 | |
Cash flow per share (Unadj.) | Rs | 45.3 | 51.7 | 61.6 | 61.6 | 14.4 | |
Dividends per share (Unadj.) | Rs | 3.00 | 3.00 | 0 | 0 | 0 | |
Adj. dividends per share | Rs | 3.00 | 3.00 | 0.00 | 0.00 | 0.00 | |
Dividend yield (eoy) | % | 0.8 | 0.8 | 0 | 0 | 0 | |
Book value per share (Unadj.) | Rs | 307.0 | 341.1 | 374.5 | 374.5 | 376.5 | |
Adj. book value per share | Rs | 307.0 | 341.1 | 374.5 | 374.5 | 376.5 | |
Shares outstanding (eoy) | m | 20.54 | 20.54 | 20.54 | 20.54 | 20.54 | |
Bonus/Rights/Conversions | PP | - | - | - | - | ||
Price / Sales ratio | x | 0.8 | 0.6 | 0.4 | 0.4 | 0.6 | |
Avg P/E ratio | x | 12.2 | 10.4 | 7.7 | 7.7 | -89.3 | |
P/CF ratio (eoy) | x | 8.4 | 7.1 | 5.0 | 5.0 | 19.7 | |
Price / Book Value ratio | x | 1.2 | 1.1 | 0.8 | 0.8 | 0.8 | |
Dividend payout | % | 9.6 | 8.5 | 0 | 0 | 0 | |
Avg Mkt Cap | Rs m | 7,815 | 7,528 | 6,348 | 6,348 | 5,833 | |
No. of employees | `000 | 3.6 | 3.5 | NA | NA | NA | |
Total wages/salary | Rs m | 1,226 | 1,799 | 2,331 | 2,331 | 2,179 | |
Avg. sales/employee | Rs Th | 2,674.6 | 3,773.8 | NM | NM | NM | |
Avg. wages/employee | Rs Th | 339.7 | 508.6 | NM | NM | NM | |
Avg. net profit/employee | Rs Th | 178.0 | 204.3 | NM | NM | NM |
ELDER PHARMA INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 9,653 | 13,348 | 16,417 | 16,417 | 10,089 | |
Other income | Rs m | 87 | 265 | 327 | 327 | 257 | |
Total revenues | Rs m | 9,739 | 13,613 | 16,744 | 16,744 | 10,346 | |
Gross profit | Rs m | 1,331 | 1,990 | 2,734 | 2,734 | -792 | |
Depreciation | Rs m | 287 | 340 | 441 | 441 | 361 | |
Interest | Rs m | 281 | 1,016 | 1,548 | 1,548 | 2,756 | |
Profit before tax | Rs m | 849 | 900 | 1,071 | 1,071 | -3,653 | |
Minority Interest | Rs m | 7 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 8 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | -45 | 15 | -28 | -28 | 3,713 | |
Tax | Rs m | 177 | 193 | 219 | 219 | 125 | |
Profit after tax | Rs m | 642 | 723 | 824 | 824 | -65 | |
Gross profit margin | % | 13.8 | 14.9 | 16.7 | 16.7 | -7.8 | |
Effective tax rate | % | 20.8 | 21.4 | 20.5 | 20.5 | -3.4 | |
Net profit margin | % | 6.7 | 5.4 | 5.0 | 5.0 | -0.6 |
ELDER PHARMA BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 8,278 | 8,782 | 8,791 | 8,791 | 9,240 | |
Current liabilities | Rs m | 5,803 | 6,957 | 9,998 | 9,998 | 9,998 | |
Net working cap to sales | % | 25.6 | 13.7 | -7.4 | -7.4 | -7.5 | |
Current ratio | x | 1.4 | 1.3 | 0.9 | 0.9 | 0.9 | |
Inventory Days | Days | 91 | 80 | 54 | 54 | 46 | |
Debtors Days | Days | 107 | 93 | 89 | 89 | 60 | |
Net fixed assets | Rs m | 7,425 | 8,973 | 9,631 | 9,631 | 10,124 | |
Share capital | Rs m | 206 | 206 | 206 | 206 | 206 | |
"Free" reserves | Rs m | 5,436 | 5,790 | 6,121 | 6,121 | 5,582 | |
Net worth | Rs m | 6,307 | 7,006 | 7,693 | 7,693 | 7,734 | |
Long term debt | Rs m | 5,095 | 5,825 | 7,039 | 7,039 | 4,889 | |
Total assets | Rs m | 17,415 | 19,998 | 24,925 | 24,925 | 22,882 | |
Interest coverage | x | 4.0 | 1.9 | 1.7 | 1.7 | -0.3 | |
Debt to equity ratio | x | 0.8 | 0.8 | 0.9 | 0.9 | 0.6 | |
Sales to assets ratio | x | 0.6 | 0.7 | 0.7 | 0.7 | 0.4 | |
Return on assets | % | 5.3 | 8.7 | 9.5 | 9.5 | 11.8 | |
Return on equity | % | 10.2 | 10.3 | 10.7 | 10.7 | -0.8 | |
Return on capital | % | 9.6 | 15.0 | 17.6 | 17.6 | 22.3 | |
Exports to sales | % | 2.4 | 2.1 | 1.9 | 1.9 | 3.0 | |
Imports to sales | % | 3.6 | 2.3 | 1.8 | 1.8 | 0.4 | |
Exports (fob) | Rs m | 228 | 280 | 318 | 318 | 307 | |
Imports (cif) | Rs m | 351 | 306 | 291 | 291 | 43 | |
Fx inflow | Rs m | 228 | 280 | 318 | 318 | 307 | |
Fx outflow | Rs m | 388 | 334 | 361 | 361 | 125 | |
Net fx | Rs m | -160 | -54 | -43 | -43 | 181 |
ELDER PHARMA CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 657 | 148 | 194 | 166 | 11,754 | |
From Investments | Rs m | -1,507 | -1,711 | -632 | -632 | -561 | |
From Financial Activity | Rs m | 2,734 | 433 | -67 | -39 | -6,762 | |
Net Cashflow | Rs m | 1,885 | -1,131 | -506 | -506 | 4,432 |
Share Holding
|
Company Information
|
CHM: J. Saxena | COMP SEC: S. P. Date | YEAR OF INC: 1900 | BSE CODE: 532322 | FV (Rs): 10 | DIV YIELD (%): - |
More Pharmaceuticals Company Fact Sheets: AMAR REMEDIES AJANTA PHARMA STRIDES PHARMA SCIENCE CIPLA ALEMBIC
Compare ELDER PHARMA With: AMAR REMEDIES AJANTA PHARMA STRIDES PHARMA SCIENCE CIPLA ALEMBIC
Compare ELDER PHARMA With: MYLAN (US) ACTAVIS (US) ADCOCK INGRAM (S. Africa) TEVA PHARMA (Israel)
Indian share markets witnessed volatile trading activity throughout the day today and ended lower.
Ajit Dayal on how India's vaccine strategy will impact the markets.
Narayana Murthy was one of the first unicorn founders to get the backing of this entity...
There is no stopping this 11-bagger stock from significant upside.
In this video I tell you the three Nifty ETFs I think are the best.
In this video, I'll you what I think is the real reason behind yesterday's market crash.
More